Janus Henderson Group PLC Grows Stock Holdings in Revvity Inc. $RVTY

Janus Henderson Group PLC grew its stake in Revvity Inc. (NYSE:RVTY) by 2.3% during the first quarter, Holdings Channel.com reports. The fund owned 8,348,127 shares of the company’s stock after purchasing an additional 186,956 shares during the quarter. Janus Henderson Group PLC owned approximately 0.07% of Revvity worth $731,386,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Ascentis Independent Advisors purchased a new stake in shares of Revvity in the first quarter valued at approximately $29,000. CYBER HORNET ETFs LLC purchased a new position in Revvity during the 2nd quarter worth $32,000. Cromwell Holdings LLC raised its position in Revvity by 141.4% during the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after purchasing an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new stake in Revvity during the 2nd quarter valued at $34,000. Finally, SJS Investment Consulting Inc. lifted its holdings in shares of Revvity by 5,210.0% in the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after buying an additional 521 shares during the period. Institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

RVTY has been the topic of several research reports. Evercore restated an “outperform” rating and set a $125.00 price target on shares of Revvity in a research note on Monday, July 6th. Weiss Ratings upgraded shares of Revvity from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Stifel Nicolaus cut their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. TD Cowen restated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Finally, Wolfe Research initiated coverage on shares of Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $108.36.

Revvity Stock Up 1.7%

NYSE:RVTY opened at $113.36 on Thursday. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $118.30. The company has a market cap of $12.65 billion, a PE ratio of 54.24, a P/E/G ratio of 2.19 and a beta of 1.09. The company’s 50 day moving average is $105.83 and its two-hundred day moving average is $99.75.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the company posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Analysts anticipate that Revvity Inc. will post 5.25 EPS for the current year.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.